Fifty years of multicentric Castleman's disease

Castleman B, 1954, 40231. N Engl J Med, 250, 1001, 10.1056/NEJM195406102502308

Castleman B, 1956, Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer, 9, 822

Lachant NA, 1985, Multicentric angiofollicular lymph node hyperplasia (Castle-man's disease) followed by Kaposi's sarcoma in two homo-sexual males with the acquired immunodeficiency syndrome (AIDS). Am J Clin Pathol, 83, 27

10.1126/science.7997879

Moore PS, 1995, New Engl J Med, 332, 1181, 10.1056/NEJM199505043321801

Buonaguro FM, 1996, Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer, 65, 25

Cesarman E, 1995, Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med, 332, 1186

Luppi M, 2000, N Engl J Med, 343, 1378, 10.1056/NEJM200011093431905

Kapelushnik J, 2001, Br J Haematol, 113, 425, 10.1046/j.1365-2141.2001.02740.x

Matsushima AY, 1999, Am J Surg Pathol, 23, 1393, 10.1097/00000478-199911000-00010

Rywlin AM, 1983, Coexistence of Castleman's disease and Kaposi's sarcoma. Report of a case and a speculation. Am J Dermatopathol, 277

Chen KT, 1984, Am J Surg Pathol, 8, 287, 10.1097/00000478-198404000-00006

Oksenhendler E, 1996, Aids, 10, 61, 10.1097/00002030-199601000-00009

Soulier J, 1995, Blood, 86, 1276, 10.1182/blood.V86.4.1276.bloodjournal8641276

10.1073/pnas.96.8.4546

Parravinci C, 1997, Am J Pathol, 151, 1517

Dupin N, 2000, Blood, 95, 1406, 10.1182/blood.V95.4.1406.004k26_1406_1412

Du MQ, 2001, HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood, 97, 2130

Oksenhendler E, 2002, Blood, 99, 2331, 10.1182/blood.V99.7.2331

Izuchukwu IS, 2003, An unusual pre-sentation of Castleman's Disease: a case report. BMC Infect Dis, 3: 20

Van Kooten C, 1993, Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells. Leukemia, 7, 618

Molden J, 1997, A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem, 272, 19625

Osborne J, 1999, KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol, 60, 921

Mullberg J, 2000, J Immunol, 164, 4672, 10.4049/jimmunol.164.9.4672

Li H, 2001, Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling. J Virol, 75, 3325

Boulanger MJ, 2004, J Mol Biol, 335, 641, 10.1016/j.jmb.2003.10.070

Aoki Y, 1999, Blood, 93, 4034, 10.1182/blood.V93.12.4034

Oksenhendler E, 2000, Blood, 96, 2069, 10.1182/blood.V96.6.2069

Klouche M, 2002, Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells. AIDS, 16, 9

Chatterjee M, 2002, Viral IL-6-induced cell proliferation and immune evasion of inter-feron activity. Science, 298, 1432

10.1073/pnas.96.8.4546

Wang L, 2004, Castleman's tumours and production of autoantibody in paraneoplastic pemphigus. Lancet, 363, 525

Day JR, 2003, Castleman's disease associated with myasthenia gravis. Ann Thorac Surg, 75, 1648

Jones KD, 1999, Blood, 94, 2871, 10.1182/blood.V94.8.2871

Oksenhendler E, 1996, AIDS, 10, 61, 10.1097/00002030-199601000-00009

10.1002/1096-8652(200102)66:2<148::AID-AJH1034>3.0.CO;2-P

10.1093/jnci/92.22.1823

Portsmouth S, 2003, AIDS, 17, 17, 10.1097/00002030-200307250-00001

10.1097/00002030-199910220-00014

Aaron L, 2002, Human herpesvirus 8-positive Castleman disease in human immunodeficiency virus-infected patients: the impact of highly active antiretroviral therapy. Clin Infect Dis, 35, 880

Zietz C, 1999, N Engl J Med, 340, 1923, 10.1056/NEJM199906173402415

Strohal R, 1998, Br J Haematol, 103, 788, 10.1046/j.1365-2141.1998.01038.x

Nord JA, 2003, Int J STD AIDS, 14, 61, 10.1258/095646203321043309

Kumari P, 2000, Clin Infect Dis, 31, 602, 10.1086/313979

Katsume A, 2002, Cytokine, 20, 304, 10.1006/cyto.2002.2012

Nishimoto N, 2000, Blood, 95, 56, 10.1182/blood.V95.1.56

10.1002/ajh.10310

Jung CP, 2004, Am J Hematol, 75, 176, 10.1002/ajh.10467

Avivi I, 2003, Clinical use of rituximab in haematological malignancies. Br J Cancer, 89, 1389

Alas S, 2001, Cancer Res, 61, 5137

10.1182/blood.V98.12.3473

Ide M, 2003, Successful treatment of multicentric Castleman's disease with bilateral orbital tumour using rituximab. Br J Haematol, 121, 818

10.1182/blood-2003-03-0951

Martin DF, 1999, N Engl J Med, 340, 1063, 10.1056/NEJM199904083401402

Mazzi R, 2001, AIDS, 15, 2061, 10.1097/00002030-200110190-00026

Low P, 1998, Eur J Med Res, 3, 461

Luppi M, 2002, Trans-plantation, 74, 131

Casper C, 2004, Remission of HHV-8 and HIV-associated multicentric Castle- man disease with ganciclovir treatment. Blood, 103, 1632

Senanayake S, 2003, J Med Virol, 71, 399, 10.1002/jmv.10500